Discovery of novel pyridone-benzamide derivatives possessing a 1-methyl-2-benzimidazolinone moiety as potent EZH2 inhibitors for the treatment of B-cell lymphomas
Article in Bioorganic & Medicinal Chemistry (April 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Bioorganic & Medicinal Chemistry (April 2024)
Book chapter (January 2024)
Article in Frontiers in Oncology (March 2023)